.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Managing patients co-prescribed benzodiazepines and opioids presents significant clinical challenges in primary care. A recent pilot study highlights the value of benzodiazepine tapering support through cognitive-behavioral therapy (CBT). Researchers evaluated whether adding CBT to a standard taper protocol could improve outcomes for patients facing the risks of high-risk medication co-use.
The trial compared a CBT-enhanced taper against a standard health education control. Participants rated both interventions as logical and useful. Although treatment engagement remained similar across groups, the results were promising. Approximately 60% of patients in both conditions achieved at least a 50% reduction in their benzodiazepine dose by the two-month follow-up. Consequently, this reduction significantly lowers the risk of adverse drug-related outcomes and overdose.
While the study did not find statistically significant differences between groups for dose reduction, effect sizes favored the CBT group regarding psychological symptoms. Specifically, patients receiving CBT showed better outcomes for anxiety severity and anxiety sensitivity. Therefore, addressing psychological barriers appears crucial during the tapering process. This behavioral adjunct helps patients manage the distress that often triggers a return to higher drug doses.
Implementing behavioral interventions alongside pharmacological tapering addresses the psychological hurdles of medication cessation. Because high anxiety sensitivity often hinders tapering efforts, CBT provides patients with necessary coping mechanisms. Clinicians should consider psychological adjuncts to improve safety in patients using high-risk drug combinations. By integrating these strategies, primary care providers can better manage the dual risks associated with opioid and benzodiazepine co-use.
Patients often experience rebound anxiety and heightened pain sensitivity during withdrawal. The presence of opioids complicates the physiological and psychological response, making a structured support system essential for safety.
CBT helps patients manage anxiety symptoms and catastrophic thinking about pain. This behavioral support makes the dose reduction more tolerable and sustainable over time by providing non-pharmacological coping tools.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a qualified healthcare provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A pilot study explores using CBT to help primary care patients reduce benzodiazepine use while co-prescribed opioids, showing promising anxiety reduction....
3 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
